German Trade Distributors Stock News

Heidelberger Druckmaschinen walked into this earnings day priced for distress, with the stock at €1.40 and a weak short term return profile over the past week. The market has treated it as a cheap cyclical print supplier. The Q1 numbers instead spotlight a sharper profitability squeeze than that simple value story suggests. Sales fell to €404m while adjusted EBITDA margin slid to just 0.2%. That drop in earnings power, not the top line alone, is what now challenges the easy “deep value”...

Deutsche Rohstoff stock came into this earnings print looking like a deep value outlier, trading on about 3x trailing P/E while carrying a 12‑month revenue base above €300m and a net margin above 40%. The headline from Q2 is simple. Profit momentum slowed sharply against Q1, yet earnings over the past year still sit far above the prior period and keep that low multiple in focus. With the share price at €93.40 after the first full day of trading post release, the key question now is how...

After a difficult three years in which Hugo Boss shares have fallen about 41.6%, the stock now trades around €37.59 and the valuation checks point to a picture that looks neither clearly cheap nor clearly expensive. The share price decline of about 41.6% over three years suggests long term holders have absorbed a significant drawdown that raises the bar for any fresh investment case. Frasers Group lifting its stake to nearly 48% can support confidence in Hugo Boss, while ongoing challenges...

Wacker Neuson (XTRA:WAC) released its second-quarter and half-year 2026 earnings on 13 August, reporting higher sales and net income compared with the same periods a year earlier. See our latest analysis for Wacker Neuson. At a share price of €20.85, Wacker Neuson has a 90 day share price return of 16.22%, while the year to date share price return is down 16.43% and the 3 year total shareholder return is 18.20%. This indicates that recent momentum has picked up following a weaker period. If...

SCHOTT Pharma KGaA (XTRA:1SXP) reported third quarter 2026 results that combined higher sales with weaker profitability, giving investors fresh numbers on revenue momentum and margin pressure as of June 30. See our latest analysis for SCHOTT Pharma KGaA. The latest earnings come against a backdrop of strong recent momentum in SCHOTT Pharma KGaA's share price, with a 90 day share price return of 36.55% and a year to date share price return of 54.55%, even though the 1 year total shareholder...

With Christine Lagarde warning that Europe’s old growth engine is wearing out and policy makers floating ideas like an EU wide corporate form and deeper capital markets, the region’s big universal and investment banks sit at a crossroads. For investors, this mix of pressure and potential reform can create rare mispricing. This article walks through three EU banking stocks exposed to these shifts and explains what their capital markets focus may mean for how you think about your portfolio. The...

Merck KGaA (XTRA:MRK) recently raised its 2026 guidance, now expecting group net sales of about €21b to €21.8b and EPS pre of €7.90 to €8.60, which has refocused attention on the stock. See our latest analysis for Merck KGaA. At a share price of €138.35, Merck KGaA has seen a 9.45% 90 day share price return and a 14.06% year to date share price return. The 1 year total shareholder return of 26.40% contrasts with declines over 3 and 5 years, pointing to renewed but still fragile momentum after...

Wüstenrot & Württembergische (XTRA:WUW) has drawn fresh attention after reporting €104 million in half year net income and confirming its 2026 earnings guidance range of €120 million to €150 million. See our latest analysis for Wüstenrot & Württembergische. The recent confirmation of Wüstenrot & Württembergische’s 2026 earnings guidance came against a share price of €14.14, with the stock showing a modest 1 year total shareholder return of 2.39% and a 5 year total shareholder return that has...

TAG Immobilien (XTRA:TEG) reported second quarter 2026 results, with sales of €130.02 million and net income of €76.45 million, as investors weigh higher revenue against lower earnings and earnings per share. See our latest analysis for TAG Immobilien. The mixed second quarter results come as TAG Immobilien’s share price has slipped recently, with a 7 day share price return of 5.24% and a 90 day share price return of 9.12%. The 3 year total shareholder return of 36.30% contrasts with a 1 year...

In recent weeks, the European market has shown resilience amid geopolitical uncertainties and fluctuating energy prices, with the STOXX Europe 600 Index experiencing a slight decline of 0.36%. As investors navigate these complex conditions, identifying stocks with strong fundamentals and growth potential becomes crucial; this article highlights three lesser-known European companies that may offer promising opportunities in such a dynamic environment.

The latest analyst coverage could presage a bad day for Allianz SE ( ETR:ALV ), with the analysts making...

It looks like PEH Wertpapier AG ( FRA:PEH ) is about to go ex-dividend in the next three days. The ex-dividend date is...

Brenntag (XTRA:BNR) reported second quarter 2026 earnings that caught investor attention, with sales of €4,263 million and net income of €179 million, compared with €3,869 million and €42 million a year earlier. See our latest analysis for Brenntag. Brenntag’s recent earnings release comes after a period of firm share price momentum, with a year to date share price return of 24.38% and a 1 year total shareholder return of 16.91%, despite weaker total shareholder returns over 3 and 5 years. If...

Henkel KGaA (XTRA:HEN3) reported half year 2026 earnings with sales of €10.35b and net income of €988m, both slightly lower than a year earlier. This earnings update is now in focus for investors. See our latest analysis for Henkel KGaA. Henkel KGaA shares trade at €75.52, with a 90 day share price return of 15.26% and year to date share price return of 8.41%, while the 1 year total shareholder return is 5.78%. This suggests momentum has picked up recently despite softer half year...

Paul Hartmann stock came into this earnings season looking cheap on a P/E of 7.1x with a 4% dividend, yet shares have slipped over the past month and were down again around the results. The market is treating this as a value story that might never re rate. The headline from H1 says something different. Earnings per share for the half year landed at €15.35 on revenue of €1,251.95m. That supports trailing earnings of €28.13 per share and a trailing net margin of 4%. For a medical equipment...

Q2 results and steady 2026 guidance draw investor attention 1&1 (XTRA:1U1) caught investors’ attention after reporting second quarter 2026 results that showed higher sales but lower net income and earnings per share, alongside guidance for flat service revenue in 2026 versus 2025. See our latest analysis for 1&1. 1&1’s recent earnings and flat 2026 service revenue guidance come after a mixed price pattern, with the share price up 6% over the past week but down 14.86% year to date, while the 3...

Einhell Germany stock closed at €72.80 on Wednesday, roughly flat over the past three months, while Q2 earnings quietly told a stronger story than the share price suggests. The headline is simple: this was a quarter about resilient profitability rather than breakneck growth. Revenue reached €329.696 million and net income came in at €23.273 million, keeping the trailing net margin near 6.5%. That margin stability, combined with a P/E of 10.8 that sits below European consumer durables peers,...

Daimler Truck Holding (XTRA:DTG) is in focus after its 7 August 2026 earnings release, which showed higher quarterly net income and basic earnings per share alongside a small decline in first half sales. See our latest analysis for Daimler Truck Holding. The recent earnings release appears to have supported Daimler Truck Holding’s share price momentum, with a 30 day share price return of 6.35% and a year to date share price return of 20.53%, alongside a 3 year total shareholder return of...

BASF stock has delivered a solid 33.9% return over the past three years, yet the valuation checks paint a more muted picture that suggests the shares may now be closer to fairly priced than clearly cheap. Over the past three years BASF has returned 33.9%, which puts recent gains at the forefront of any discussion about how much further the stock can reasonably go from here. Recent news around BASF's push into recyclable foam packaging and bio based bisphenol alternatives can support long...

JDC Group stock closed at €22.10 on Wednesday after a weak week for shareholders, with the price down about 6.8% over seven days. The immediate reaction is cool, yet the headline from this earnings release is clear. Revenue in Q2 reached €67.3m, with H1 turnover and EBITDA shaped heavily by the FMK acquisition and recurring platform fees. The tension for you as an investor now sits between that short term share price wobble and a longer horizon that weighs current valuation metrics, including...

Why Bechtle’s Latest Earnings Matter For Shareholders Bechtle (XTRA:BC8) has drawn fresh attention after reporting second quarter 2026 results that showed higher sales, net income and earnings per share compared with the same period a year earlier. See our latest analysis for Bechtle. The latest earnings release has arrived after a sharp 16.12% 1 month share price return and a 14.68% 3 month share price return for Bechtle, even though the year to date share price return is down 20.16% and the...

Scout24 (XTRA:G24) drew investor attention on 6 August 2026 after reporting second quarter and half year 2026 results, with higher sales, revenue and net income than the same periods in 2025. See our latest analysis for Scout24. Scout24's latest earnings release comes after a mixed year for investors, with the share price delivering a 6.05% 90 day return and a 1 year total shareholder return that is down 31.36%, while the 3 year total shareholder return is up 31.85%. If this earnings update...

Health Canada approval puts Bayer stock in focus Bayer (XTRA:BAYN) is back on investors’ radar after Health Canada expanded the indication for LYNKUET to treat moderate to severe vasomotor symptoms linked to adjuvant endocrine therapy in breast cancer. The approval, supported by the OASIS-4 study, gives Bayer the first authorized treatment option in Canada for this specific patient group. This development could prompt investors to reassess the company’s pharmaceuticals footprint alongside its...

Half year results and buyback completion put Beiersdorf in focus Beiersdorf (XTRA:BEI) is back on investors’ radar after reporting half year 2026 results that showed slightly lower sales but broadly stable profitability compared with 2025, alongside the completion of a previously announced share buyback tranche. See our latest analysis for Beiersdorf. Beiersdorf’s share price closed at €77.0 and has fallen 17.04% on a year to date basis, while the 1 year total shareholder return declined...